A carregar...
PRACTICAL RECOMMENDATIONS FOR THE USE OF SUNITINIB IN THE TREATMENT OF METASTATIC KIDNEY CANCER. ADVERSE EVENTS – POTENTIAL MARKERS OF ITS EFFICACY
The paper deals with the specific features of sunitinib tolerance in the treatment of metastatic renal-cell carcinoma. It considers in detail the drug’s side effects that are potential biomarkers of its efficacy.
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
ABV-press
2013-06-01
|
| Colecção: | Onkourologiâ |
| Assuntos: | |
| Acesso em linha: | https://oncourology.abvpress.ru/oncur/article/view/91 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|